| Affymax to Present at RBC Capital Markets Healthcare Conference - PR-Inside.com (Pressemitteilung) |
|
|
Affymax"s product candidate, Hematide?, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. ... |